Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Prescott

Showing results (351-360 of 377) with videos related to

Pageof 38
Sort By:
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|February 8, 2005
Antinociceptive effect of Nidularium procerum: a Bromeliaceae from the Brazilian coastal rain forestF C Amendoeira, V S Frutuoso, L M Chedier, et al.
Plos One|September 27, 2013
Bacterial clearance is improved in septic mice by platelet-activating factor-acetylhydrolase (PAF-AH) administrationMariana G A Teixeira-da-Cunha, Rachel N Gomes, Nathassia Roehrs, et al.
The Milbank Quarterly|March 15, 2006
The Indiana Chronic Disease Management ProgramMarc B Rosenman, Ann M Holmes, Ronald T Ackermann, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 1994
Therapy monitoring in human and canine soft tissue sarcomas using magnetic resonance imaging and spectroscopyD M Prescott, H C Charles, H D Sostman, et al.
AIDS and Behavior|July 11, 2025
Barriers and Facilitators to PrEP Adherence among Transgender and Non-binary Individuals: A Mixed-Methods Analysis of Psychosocial Factors and Health Belief Model ConstructsD Paltin, M Prescott, J Ma, et al.
The Journal of Clinical Investigation|June 15, 1996
Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipaseD M Stafforini, K Satoh, D L Atkinson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Synergism between platelet-activating factor-like phospholipids and peroxisome proliferator-activated receptor gamma agonists generated during low density lipoprotein oxidation that induces lipid body formation in leukocytesEdson F de Assis, Adriana R Silva, Lara F C Caiado, et al.
The Journal of Biological Chemistry|March 30, 2001
Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonistsS S Davies, A V Pontsler, G K Marathe, et al.
Pharmacy (Basel, Switzerland)|January 17, 2023
Characteristics of Successful International Pharmacy PartnershipsGina M Prescott, Lauren Jonkman, Rustin D Crutchley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2002
Monocyte chemoattractant protein-1 and 5-lipoxygenase products recruit leukocytes in response to platelet-activating factor-like lipids in oxidized low-density lipoproteinAdriana R Silva, Edson F de Assis, Lara F C Caiado, et al.
Pageof 38

Showing results (351-360 of 377) with videos related to

Sort By:
Pageof 38
Phytomedicine : International Journal of Phytotherapy and Phytopharmacology|February 8, 2005
Antinociceptive effect of Nidularium procerum: a Bromeliaceae from the Brazilian coastal rain forestF C Amendoeira, V S Frutuoso, L M Chedier, et al.
Plos One|September 27, 2013
Bacterial clearance is improved in septic mice by platelet-activating factor-acetylhydrolase (PAF-AH) administrationMariana G A Teixeira-da-Cunha, Rachel N Gomes, Nathassia Roehrs, et al.
The Milbank Quarterly|March 15, 2006
The Indiana Chronic Disease Management ProgramMarc B Rosenman, Ann M Holmes, Ronald T Ackermann, et al.
International Journal of Radiation Oncology, Biology, Physics|January 15, 1994
Therapy monitoring in human and canine soft tissue sarcomas using magnetic resonance imaging and spectroscopyD M Prescott, H C Charles, H D Sostman, et al.
AIDS and Behavior|July 11, 2025
Barriers and Facilitators to PrEP Adherence among Transgender and Non-binary Individuals: A Mixed-Methods Analysis of Psychosocial Factors and Health Belief Model ConstructsD Paltin, M Prescott, J Ma, et al.
The Journal of Clinical Investigation|June 15, 1996
Platelet-activating factor acetylhydrolase deficiency. A missense mutation near the active site of an anti-inflammatory phospholipaseD M Stafforini, K Satoh, D L Atkinson, et al.
Journal of Immunology (Baltimore, Md. : 1950)|August 7, 2003
Synergism between platelet-activating factor-like phospholipids and peroxisome proliferator-activated receptor gamma agonists generated during low density lipoprotein oxidation that induces lipid body formation in leukocytesEdson F de Assis, Adriana R Silva, Lara F C Caiado, et al.
The Journal of Biological Chemistry|March 30, 2001
Oxidized alkyl phospholipids are specific, high affinity peroxisome proliferator-activated receptor gamma ligands and agonistsS S Davies, A V Pontsler, G K Marathe, et al.
Pharmacy (Basel, Switzerland)|January 17, 2023
Characteristics of Successful International Pharmacy PartnershipsGina M Prescott, Lauren Jonkman, Rustin D Crutchley, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 9, 2002
Monocyte chemoattractant protein-1 and 5-lipoxygenase products recruit leukocytes in response to platelet-activating factor-like lipids in oxidized low-density lipoproteinAdriana R Silva, Edson F de Assis, Lara F C Caiado, et al.
Pageof 38